The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.

A new computational biology pipeline has mapped out more than 13,000 groups of protein-coding genes conserved across grasses, ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

Ankur Mutreja, Tikesh Bisen, and Balaji Veeraraghavan address the urgent global health challenge of antimicrobial resistance.

Swiss pharmaceutical Roche has announced plans to invest billions in the US within the next five years, creating 12,000 new ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights ...

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360tm -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies for rare and common diseases. With momentum building from ...

Companion Diagnostics MarketThe global market for companion diagnostics is set for exponential growth, projected to expand from USD 5,700.5 million in 2024 to USD 11,682.8 million by 2035, registering ...